VivoSim Labs, Inc. Common Stock

VIVSNASDAQUSD
1.20 USD
0.07 (6.28%)🟢PRE MARKET (AS OF 07:00 AM EDT)
🟢Market: OPEN

VivoSim Labs, Inc. Common Stock (VIVS) is currently trading at $1.20. Technical indicators currently signal "Strong Sell". Key drivers include negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. VIVS is fairly valued relative to its sector peers based on current multiples.

Technical & fundamental data as of Jun 17, 2026.

Open?$1.16
High?$1.30
Low?$1.16
Prev. Close?$1.13
Volume?2.0K
Avg. Volume?51.6K
VWAP?$1.25
Rel. Volume?0.04x
Bid / Ask
Bid?$0.99 × 100
Ask?$1.30 × 100
Spread?$0.31
Midpoint?$1.14
Valuation & Ratios
Market Cap?3.3M
Shares Out?N/A
Float?2.5M
Float %?97.5%
P/E Ratio?N/A
P/B Ratio?0.74
EPS?-$0.42
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
VivoSim Labs Inc formerly, Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases. It is now offering liver toxicology predictive screening and research services as well as working on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies at all stages of drug development.
Employees
9
Market Cap
3.3M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed
2011-08-16
Address
11555 SORRENTO VALLEY ROAD
SAN DIEGO, CA 92121
Phone: 858-224-1000
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bearish(-3/3)
Medium-Term (Wave)? Bearish(-3/3)
Short-Term (Ripple)? Bearish(-1/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental Outlook
Loading...
Short InterestLow
Short % of Float?1.31%Low
Short Interest?33.3K
Days to Cover?1.0
Free Float2.5M
Avg Daily Volume51.6K
Settlement Date2026-05-29
Financial Health
Current Ratio?2.44Strong
Quick Ratio?2.44Strong
Cash Ratio?1.73Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
83/100
P/E?
N/A
P/B?
Peers
100
S&P
97
0.74CHEAP
P/S?
Peers
100
S&P
3
23.03HIGH
P/FCF?
N/A
EV/EBITDA?
Peers
100
S&P
97
0.1CHEAP
EV/Sales?
S&P
97
-7.16CHEAP
Returns & Efficiency
ROE?
S&P
6
-27.6%WEAK
ROA?
S&P
3
-17.6%WEAK
Cash Flow & Enterprise
FCF?$-10624000
Enterprise Value?$-1017194
Fundamentals ratios updated end of day